According to Zacks, “Covetrus, Inc. provides animal-health technology and services. The Company combines practice management software, prescription management, multi-channel client engagement services and supply chain infrastructure to promote connectivity between veterinarians and their clients. Covetrus, Inc. is based in NY, United States. “
CVET opened at $14.42 on Wednesday. The firm has a market cap of $2.00 billion, a price-to-earnings ratio of -36.97 and a beta of 2.01. The company has a current ratio of 1.94, a quick ratio of 1.10 and a debt-to-equity ratio of 0.67. Covetrus has a 12 month low of $14.34 and a 12 month high of $31.24. The stock has a fifty day moving average price of $16.61 and a 200-day moving average price of $17.71.
A number of large investors have recently made changes to their positions in the stock. Kovitz Investment Group Partners LLC increased its position in Covetrus by 44.8% during the 1st quarter. Kovitz Investment Group Partners LLC now owns 1,371,034 shares of the company’s stock valued at $23,020,000 after buying an additional 423,994 shares in the last quarter. Strs Ohio increased its position in Covetrus by 102.9% during the 1st quarter. Strs Ohio now owns 48,900 shares of the company’s stock valued at $821,000 after buying an additional 24,800 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Covetrus by 51.5% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,172 shares of the company’s stock valued at $238,000 after purchasing an additional 4,820 shares during the period. Norges Bank acquired a new position in shares of Covetrus in the fourth quarter valued at about $30,146,000. Finally, Walleye Capital LLC acquired a new position in shares of Covetrus in the fourth quarter valued at about $300,000. 97.48% of the stock is currently owned by institutional investors.
Covetrus Company Profile (Get Rating)
Covetrus, Inc, together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.
- Get a free copy of the StockNews.com research report on Covetrus (CVET)
- Automatic Data Processing Is Ready To Scale New Heights
- Carl Icahn Buys More Xerox
- Xerox Holdings Stock is a Value Play
- The Kraft Heinz Turnaround Story Gains Momentum
- Microsoft (NASDAQ: MSFT) Saves The Day, For Now
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.